reference/3903082

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3903082

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	827
issn	0344-5704 1432-0843
issueIdentifier	4
pageRange	819-827
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	819
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dc39d59a35795e01dbb48d271de562c2
bibliographicCitation	Petty R, Anthoney A, Metges JP, Alsina M, Gonçalves A, Brown J, Montagut C, Gunzer K, Laus G, Iglesias Dios JL, Miguel-Lillo B, Bohan P, Salazar R. Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial). Cancer Chemother Pharmacol. 2016 Apr;77(4):819–27. doi: 10.1007/s00280-016-2991-0. PMID: 26964995.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a98088d75d84f2e4196d1c55d87c5eaf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_debc07d562a3f049af7b6b51713ab3ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcd836336961035b0ffb5db84f542e60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9c3def17de362af7aa39a5e3eaa3cf3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57392c38695e7f529f5bd0a7b0ab893f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11ac1fc85ae50e7af25648f304ceaadb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23b5a1ffa01b160549abfaa580be8914 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c16e259fe634f8f69a625ef306882eaf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c6664643348c2ddab8629aa3193d4eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1148-2645 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c69b8d61c88a0a7ac45ff73956432eef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c6cc2128380314e228045c09feb7822 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_518f18dcf7117d9bea5267dbf05256f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef10adee400547f1a572d0ab343ebea0
date	2016-03-10^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00280-016-2991-0 https://pubmed.ncbi.nlm.nih.gov/26964995
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664 https://portal.issn.org/resource/ISSN/1432-0843 https://portal.issn.org/resource/ISSN/0344-5704
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial)
discusses	http://id.nlm.nih.gov/mesh/M0512928 http://id.nlm.nih.gov/mesh/M0458175 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004938Q000188 http://id.nlm.nih.gov/mesh/D013274Q000188 http://id.nlm.nih.gov/mesh/D004943 http://id.nlm.nih.gov/mesh/D047630Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D047630Q000009 http://id.nlm.nih.gov/mesh/D009362 http://id.nlm.nih.gov/mesh/D047630Q000493 http://id.nlm.nih.gov/mesh/D000970Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7464 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9855343 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305

Showing number of triples: 1 to 60 of 60.